Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
CA 2530422 C · Owner: Depuy Synthes Products, Inc. · Inventors: Harris, Ian Ross; Yi, Chin-Feng; Gosiewska, Anna
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Cells derived from postpartum tissue and methods for their use in treatment of diseases of the heart or circulatory system are disclosed. Cells may , be used in either differentiated or undifferentiated forms in homogenous , cultures, or as populations with other cells and in conjunction with other bioactive factors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 25, 2004 and granted January 5, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 25, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 25, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.